Literature DB >> 26639245

Prognostic significance of the Musashi-2 (MSI2) gene in childhood acute lymphoblastic leukemia.

H Z Zhao, M Jia, Z B Luo, Y P Cheng, X J Xu, J Y Zhang, S S Li, Y M Tang.   

Abstract

The prognostic value of the Musashi-2 (MSI2) gene has not yet been studied in childhood acute lymphoblastic leukemia (ALL). In our study, MSI2 mRNA levels of 119 childhood patients with newly-diagnosed ALL were examined and analyzed with regard to clinical characteristics and outcomes. ALL patients demonstrated significantly higher MSI2 mRNA levels than healthy controls. In addition, MSI2 mRNA levels were correlated with the disease status and IK6 mutation status. Survival analyses showed that higher MSI2 mRNA levels predicted worse outcomes in patients with childhood ALL. Moreover, in multivariate analyses, MSI2 mRNA overexpression retained its value as an independent risk factor for overall survival (OS), but not for event free survival (EFS). We conclude that high MSI2 mRNA level predicts adverse prognosis and seems to be useful as a novel prognostic factor for patients with childhood ALL.

Entities:  

Keywords:  acute lymphoblastic leukemia; childhood; musashi-2; overall survival; prognosis.

Mesh:

Substances:

Year:  2016        PMID: 26639245     DOI: 10.4149/neo_2016_018

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  3 in total

Review 1.  RNA-Binding Proteins in Acute Leukemias.

Authors:  Konstantin Schuschel; Matthias Helwig; Stefan Hüttelmaier; Dirk Heckl; Jan-Henning Klusmann; Jessica I Hoell
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

2.  Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse.

Authors:  Yvonne Saara Gladbach; Lisa-Madeleine Sklarz; Catrin Roolf; Julia Beck; Ekkehard Schütz; Georg Fuellen; Christian Junghanss; Hugo Murua Escobar; Mohamed Hamed
Journal:  Genes (Basel)       Date:  2022-07-14       Impact factor: 4.141

3.  Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.

Authors:  Kornelia Neveling; Tuomo Mantere; Susan Vermeulen; Michiel Oorsprong; Ronald van Beek; Ellen Kater-Baats; Marc Pauper; Guillaume van der Zande; Dominique Smeets; Daniel Olde Weghuis; Marian J P L Stevens-Kroef; Alexander Hoischen
Journal:  Am J Hum Genet       Date:  2021-07-07       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.